GLENMARK LIFE SCIENCES LTD.
|
Market Cap.(`)
|
9985.35 Cr.
|
P/BV
|
4.28
|
Book Value (`)
|
190.35
|
|
52 Week High/Low ( ` )
|
906/465
|
FV/ML
|
2/1
|
P/E(X)
|
21.21
|
|
Book Closure
|
17/10/2023
|
EPS (`)
|
38.43
|
Div Yield (%)
|
0.00
|
(` in Crs.)
You can view the Standalone
Income Statement
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 2283.21 | 2047.84 | 2087.45 | 1861.40 | 1494.34 |
| Other Operating Revenues | 0.00 | 113.38 | 35.77 | 23.77 | 42.97 |
| Total Operating Revenues | 2283.21 | 2161.22 | 2123.21 | 1885.17 | 1537.31 |
| | | | | | |
| Other Income | 12.04 | 28.96 | 14.70 | 0.81 | 11.99 |
| Total Revenue | 2295.26 | 2190.18 | 2137.92 | 1885.98 | 1549.30 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1058.58 | 1098.53 | 1001.56 | 976.20 | 695.10 |
| Operating And Direct Expenses | 0.00 | 2.48 | 2.66 | 1.82 | 2.68 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -56.57 | -84.44 | 41.32 | -70.70 | -4.64 |
| Employee Benefit Expenses | 258.16 | 180.18 | 168.72 | 149.13 | 142.28 |
| Finance Costs | 1.55 | 0.55 | 27.96 | 87.55 | 33.52 |
| Depreciation And Amortisation Expenses | 53.45 | 42.09 | 37.88 | 33.39 | 29.37 |
| Other Expenses | 348.80 | 322.18 | 292.89 | 237.65 | 229.93 |
| Total Expenses | 1663.97 | 1561.57 | 1572.99 | 1415.03 | 1128.24 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 631.29 | 628.61 | 564.93 | 470.94 | 421.07 |
| | | | | | |
| Profit/Loss Before Tax | 631.29 | 628.61 | 564.93 | 470.94 | 421.07 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 160.40 | 150.61 | 137.63 | 112.75 | 98.54 |
| Deferred Tax | 0.00 | 11.04 | 8.57 | 6.62 | 9.43 |
| Total Tax Expenses | 160.40 | 161.65 | 146.20 | 119.36 | 107.97 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 470.89 | 466.96 | 418.72 | 351.58 | 313.10 |
| | | | | | |
| Profit/Loss From Continuing Operations | 470.89 | 466.96 | 418.72 | 351.58 | 313.10 |
| | | | | | |
| Profit/Loss For The Period | 470.89 | 466.96 | 418.72 | 351.58 | 313.10 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 38.43 | 38.11 | 35.63 | 32.61 | 1597.37 |
| Diluted EPS (Rs.) | 38.38 | 38.11 | 35.63 | 32.61 | 1597.37 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 385.96 | 128.65 | 0.00 | 0.00 |
| Equity Dividend Rate (%) | 1125.00 | 1050.00 | 1050.00 | 0.00 | 0.00 |